Observational studyJournal of the American Heart Association2024

Eighteen-Month Real-World Experience Using Mavacamten for Treatment of Obstructive Hypertrophic Cardiomyopathy in a Racially Diverse Population.

Diego Ramonfaur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.